R. Kunnavakkam

发表

Effects of extended pleurectomy and decortication on quality of life and pulmonary function in patients with malignant pleural mesothelioma.

W. Vigneswaran, H. Kindler, A. D. Celauro, 2015, The Annals of thoracic surgery.

Reply to H.W. Daniell and to L. Azoulay and S. Suissa

R. Weichselbaum, T. Karrison, S. Liauw, 2010 .

Influence of related donor age on outcomes after peripheral blood stem cell transplantation.

R. Larson, W. Stock, A. Wickrema, 2012, Cytotherapy.

Late toxicity and quality of life after definitive treatment of prostate cancer: redefining optimal rectal sparing constraints for intensity-modulated radiation therapy

C. Pelizzari, S. Liauw, S. Chennupati, 2014, Cancer medicine.

Corneal Abrasion in Hysterectomy and Prostatectomy: Role of Laparoscopic and Robotic Assistance

S. Eggener, D. Glick, Isaac Parakati, 2015, Anesthesiology.

Empiric antibiotics for an elevated prostate‐specific antigen (PSA) level: a randomised, prospective, controlled multi‐institutional trial

N. Smith, J. Raman, S. Eggener, 2013, BJU international.

Pediatricians' knowledge, attitudes, and practice patterns regarding special education and individualized education programs.

M. Msall, Reshma Shah, R. Kunnavakkam, 2013, Academic pediatrics.

Chemoradiation for patients with advanced oral cavity cancer

E. Vokes, D. Haraf, E. Cohen, 2009, The Laryngoscope.

Immune reconstitution after combined haploidentical and umbilical cord blood transplant

R. Larson, J. Ulaszek, W. Stock, 2013, Leukemia & lymphoma.

A novel clofarabine bridge strategy facilitates allogeneic transplantation in patients with relapsed/refractory leukemia and high-risk myelodysplastic syndromes

M. L. Beau, R. Larson, W. Stock, 2013, Bone Marrow Transplantation.

Northern Latitude but Not Season Is Associated with Increased Rates of Hospitalizations Related to Inflammatory Bowel Disease: Results of a Multi-Year Analysis of a National Cohort

M. Bissonnette, J. Pekow, J. Gaetano, 2016, PloS one.

Ninety-day perioperative complications of pediatric robotic urological surgery: A multi-institutional study.

T. Lendvay, J. Elder, C. Koh, 2016, Journal of pediatric urology.

Amifostine induces antioxidant enzymatic activities in normal tissues and a transplantable tumor that can affect radiation response.

D. Spitz, Y. Kataoka, J. Murley, 2009, International journal of radiation oncology, biology, physics.

Statin use and risk of prostate cancer recurrence in men treated with radiation therapy.

R. Weichselbaum, T. Karrison, S. Liauw, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cediranib in patients with malignant mesothelioma: a phase II trial of the University of Chicago Phase II Consortium.

D. Gandara, E. Vokes, W. Stadler, 2012, Lung cancer.

A randomized phase 1 study of testosterone replacement for patients with low-risk castration-resistant prostate cancer.

S. Mohile, E. Posadas, W. Stadler, 2009, European urology.

A randomized pilot phase I study of modified carcinoembryonic antigen (CEA) peptide (CAP1-6D)/montanide/GM-CSF-vaccine in patients with pancreatic adenocarcinoma

T. Karrison, D. Geynisman, H. Kindler, 2013, Journal of Immunotherapy for Cancer.

Phase II Study of the Oral MEK Inhibitor Selumetinib in Advanced Acute Myelogenous Leukemia: A University of Chicago Phase II Consortium Trial

Scott E. Smith, R. Larson, W. Stock, 2013, Clinical Cancer Research.

A Phase II Study of Lapatinib in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck

Jeffrey Bozeman, J. Dancey, E. Vokes, 2012, Clinical Cancer Research.

Intensity modulated radiation therapy after radical prostatectomy: Early results show no decline in urinary continence, gastrointestinal, or sexual quality of life.

S. Eggener, S. Liauw, K. Corbin, 2013, Practical radiation oncology.

Phase II study of the oral MEK inhibitor selumetinib (AZD6244) in advanced acute myeloid leukemia (AML).

Scott E. Smith, R. Larson, W. Stock, 2012 .

Epidermal growth factor receptor inhibitor gefitinib added to chemoradiotherapy in locally advanced head and neck cancer.

Olufunmilayo I. Olopade, Mark W. Lingen, Everett E. Vokes, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chemoradiation for patients with large‐volume laryngeal cancers

E. Vokes, T. Seiwert, D. Haraf, 2012, Head & neck.

A randomized phase II study of 5-fluorouracil, hydroxyurea, and twice-daily radiotherapy compared with bevacizumab plus 5-fluorouracil, hydroxyurea, and twice-daily radiotherapy for intermediate-stage and T4N0-1 head and neck cancers.

E. Vokes, D. Haraf, K. Stenson, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

Measurements of Hepatic Metastasis on MR Imaging:: Assessment of Interobserver and Intersequence Variability.

A. Oto, Yahui Peng, Emily V M Ward, 2016, Academic radiology.

The impact of hormonal therapy on sexual quality of life in men receiving intensity modulated radiation therapy for prostate cancer.

S. Liauw, S. Chennupati, C. Son, 2015, Practical radiation oncology.

Phase II Study of the Oral MEK Inhibitor Selumetinib in Advanced Acute Myelogenous Leukemia: A University of Chicago Phase II Consortium Trial

Scott E. Smith, R. Larson, W. Stock, 2013, Clinical Cancer Research.

Statin use and risk of prostate cancer recurrence in men treated with radiation therapy.

R. Weichselbaum, T. Karrison, S. Liauw, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cediranib in patients with malignant mesothelioma: a phase II trial of the University of Chicago Phase II Consortium.

D. Gandara, E. Vokes, W. Stadler, 2012, Lung cancer.

Chemoradiation for patients with advanced oral cavity cancer

E. Vokes, D. Haraf, E. Cohen, 2009, The Laryngoscope.